Mirae Asset Global ETFs Holdings’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$150K Buy
49,802
+1,875
+4% +$8.12K ﹤0.01% 2492
2025
Q4
$173K Buy
47,927
+3,846
+9% +$23.6K ﹤0.01% 2419
2025
Q3
$391K Sell
44,081
-6,221
-12% -$63.1K ﹤0.01% 1987
2025
Q2
$465K Sell
50,302
-223
-0.4% -$1.9K ﹤0.01% 1854
2025
Q1
$434K Buy
50,525
+4,869
+11% +$46K ﹤0.01% 1945
2024
Q4
$491K Buy
45,656
+184
+0.4% +$1.42K ﹤0.01% 1932
2024
Q3
$258K Sell
45,472
-394
-0.9% -$2.27K ﹤0.01% 2239
2024
Q2
$194K Buy
+45,866
New +$186K ﹤0.01% 2264

Other funds holding AVXL

Mirae Asset Global ETFs Holdings's AVXL Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Anavex Life Sciences (AVXL) stake by 3.9% in Q1 2026, buying an estimated $8.12K and bringing the position to 49,802 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #2492.

Mirae Asset Global ETFs Holdings first reported a position in AVXL in Q2 2024 and has held it in 8 quarters since. The position peaked at $491K in Q4 2024. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 49,802 shares of Anavex Life Sciences worth $150K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 1,875 Anavex Life Sciences shares in Q1 2026, an estimated $8.12K.
  • Anavex Life Sciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2492 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Anavex Life Sciences in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Anavex Life Sciences position peaked at $491K in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.